Summary：Warburg Pincus nears $7 billion deal for PANTHERx Rare, WSJ says **Introduction** Private‑equity h

referrerpolicy="no-referrer"
style="max-width:100%;height:auto;display:block;margin:0 auto;">

Warburg Pincus nears $7 billion deal for PANTHERx Rare, WSJ says

**Introduction**
Private‑equity heavyweight Warburg Pincus is reportedly in the final stages of a $7 billion takeover of PANTHERx Rare, a specialty‑pharmacy firm that focuses on high‑cost, low‑volume medications. The Wall Street Journal first broke the story, noting that the transaction